Headquartered in Lake Forest, CA Fiscal year ends December NASDAQ: STAA staar.com
STAAR Surgical Company (NASDAQ: STAA) is a global ophthalmic surgical company focused exclusively on implantable phakic intraocular lenses for vision correction. The company designs, develops, manufactures, and markets its EVO family of Implantable Collamer Lenses (ICLs), which use a proprietary biocompatible Collamer material to correct myopia and astigmatism without removing corneal tissue or the eye's natural crystalline lens. The EVO ICL is a minimally invasive, removable, and reversible alternative to laser-based refractive surgery (such as LASIK). STAAR has sold more than 4 million ICLs in over 85 countries, with China as its largest market (over 50% of revenue), followed by Japan, South Korea, and the United States. The company operates manufacturing and R&D facilities in California and Switzerland, and distributes through a combination of direct sales and independent distributor networks internationally. STAAR recently terminated a proposed merger with Alcon and is now pursuing a platform strategy under new CEO Warren Foust, with plans for next-generation products and a search underway for a Chief Technology Officer. Updated
Pre-Market Stock Futures: Futures are trading modestly higher after a rough start to the third quarter’s last trading week. The song remains the same: rising interest rates and oil prices once again…
Pre-Market Stock Futures: The futures are trading higher as we get set to close out the week on a possible winning note, after a massive bounce-back rally on Thursday that saw all…
W.R. Berkley and Navan have just seen some huge insider purchases. have seen some huge insider purchases, and there were some other notable insider purchases as well.
Billionaires Carl Icahn and John Malone are among insiders continuing to build stakes in their favorite stocks during the bear market.
Market volatility has not dissuaded some insiders from making big share purchases. The most notable transactions came from return buyers.
Some of the most notable purchases in the past week or so were made by return buyers. A firm associated with Mexican billionaire Carlos Slim was among them.
Insider buying slowed ahead of the third-quarter earnings reporting season, but an IPO tempted one insider, and a repeat buyer returned to boost a stake.
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
Some of the biggest insider buying since the Thanksgiving holiday has come from repeat buyers, including Bill Ackman, who continues to build his stake in a real estate firm.
Friday's top analyst upgrades and downgrades included DXC Technology, Etsy, Extreme Networks, Moderna, PagSeguro Digital, Qualcomm, Roku, Ross Stores, Royal Caribbean Cruises, Southwest Airlines, Spirit AeroSystems, StoneCo and Wayfair.
Thursday's top analyst upgrades and downgrades included ADT, Aurora Cannabis, CarMax, Shift4 Payments, Skechers USA, Tesla and Tilray.
Tuesday's top analyst upgrades and downgrades included Adobe, Advanced Micro Devices, Bank of New York Mellon, Carlyle, CF Industries, Chewy, Cleveland-Cliffs, CVS Health, Fifth Third Bancorp, Luminar Technologies, Nike, Pinterest, QuantumScape, Unity…
Monday's top analyst upgrades and downgrades included American Express, BlackBerry, FedEx, Garmin, Manchester United, MGM Resorts, Nike, Omnicom, TransUnion and Warby Parker.
Friday's top analyst upgrades and downgrades included American Express, Bumble, Cloudera, Diamondback Energy, Discover Financial, General Motors, Match, NOV and UnitedHealth.
These four Jefferies stock picks in the health care space offer outstanding upside potential for investors long term and look like very solid ideas for the rest of 2021, especially with an…
STAAR Surgical Company (NASDAQ: STAA) is a global ophthalmic surgical company focused exclusively on implantable phakic intraocular lenses for vision correction.
The Wall Street consensus 12-month price target for STAA is $28.00.
